A Systematic Literature Review of the Burden of Respiratory Syncytial Virus and Health Care Utilization Among United States Infants Younger Than 1 Year
- PMID: 35968876
- PMCID: PMC9377044
- DOI: 10.1093/infdis/jiac201
A Systematic Literature Review of the Burden of Respiratory Syncytial Virus and Health Care Utilization Among United States Infants Younger Than 1 Year
Abstract
Background: The burden and health care utilization (HCU) of respiratory syncytial virus (RSV) in US infants aged <1 year across health care settings are not well characterized.
Methods: We systematically reviewed studies of RSV and bronchiolitis published 2000-2021 (data years, 1979-2020). Outcomes included RSV hospitalization (RSVH)/bronchiolitis hospitalization rates, emergency department (ED)/outpatient (OP) visit rates, and intensive care unit (ICU) admissions or mechanical ventilation (MV) use among RSV-/bronchiolitis-hospitalized infants. Study quality was determined using standard tools.
Results: We identified 141 good-/fair-quality studies. Five national studies reported annual average RSVH rates (range, 11.6 per 1000 per year among infants aged 6-11 months in 2006 to 50.1 per 1000 per year among infants aged 0-2 months in 1997). Two national studies provided RSVH rates by primary diagnosis for the entire study period (range, 22.0-22.7 per 1000 in 1997-1999 and 1997-2000, respectively). No national ED/OP data were available. Among 11 nonnational studies, RSVH rates varied due to differences in time, populations (eg, prematurity), and locations. One national study reported that RSVH infants with high-risk comorbidities had 5-times more MV use compared to non-high-risk infants in 1997-2012.
Conclusions: Substantial data variability was observed. Nationally representative studies are needed to elucidate RSV burden and HCU.
Keywords: RSV; emergency department; infants; intensive care unit admission; lower respiratory tract infection; mechanical ventilation; outpatient; respiratory syncytial virus; respiratory syncytial virus hospitalization; systematic literature review.
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Conflict of interest statement
Potential conflicts of interest. EpidStrategies received a grant from Sanofi for this research. M. S., N. M., L. C. B., and J. P. F. are employees of EpidStrategies. C. B. N. is an employee of Sanofi and may hold shares and/or stock options in the company. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Figures
![Figure 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/9377044/bin/jiac201f1.gif)
![Figure 2.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/9377044/bin/jiac201f2.gif)
Similar articles
-
Respiratory Syncytial Virus Burden and Healthcare Utilization in United States Infants <1 Year of Age: Study of Nationally Representative Databases, 2011-2019.J Infect Dis. 2022 Aug 15;226(Suppl 2):S184-S194. doi: 10.1093/infdis/jiac155. J Infect Dis. 2022. PMID: 35968879 Free PMC article.
-
RSV-related hospitalization and outpatient palivizumab use in very preterm (born at <29 wGA) infants: 2003-2020.Hum Vaccin Immunother. 2022 Nov 30;18(6):2140533. doi: 10.1080/21645515.2022.2140533. Epub 2022 Nov 22. Hum Vaccin Immunother. 2022. PMID: 36412253 Free PMC article.
-
The burden of Respiratory Syncytial Virus (RSV) infection in the Middle East and North Africa (MENA) region across age groups: A systematic review.Vaccine. 2021 Jun 29;39(29):3803-3813. doi: 10.1016/j.vaccine.2021.05.076. Epub 2021 Jun 4. Vaccine. 2021. PMID: 34099329 Review.
-
Respiratory Syncytial Virus and All-Cause Bronchiolitis Hospitalizations Among Preterm Infants Using the Pediatric Health Information System (PHIS).J Infect Dis. 2022 Apr 1;225(7):1197-1204. doi: 10.1093/infdis/jiaa435. J Infect Dis. 2022. PMID: 32691037 Free PMC article.
-
Respiratory syncytial virus hospitalizations in US preterm infants after the 2014 change in immunoprophylaxis guidance by the American Academy of Pediatrics.J Perinatol. 2020 Aug;40(8):1135-1144. doi: 10.1038/s41372-020-0689-y. Epub 2020 Jun 4. J Perinatol. 2020. PMID: 32499597 Free PMC article. Review.
Cited by
-
Disease burden and high-risk populations for complications in patients with acute respiratory infections: a scoping review.Front Med (Lausanne). 2024 May 16;11:1325236. doi: 10.3389/fmed.2024.1325236. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38818396 Free PMC article. Review.
-
Healthcare Utilization Among Infants Covered by Medicaid and Newly Diagnosed With Respiratory Syncytial Virus.Open Forum Infect Dis. 2024 Mar 21;11(4):ofae174. doi: 10.1093/ofid/ofae174. eCollection 2024 Apr. Open Forum Infect Dis. 2024. PMID: 38595954 Free PMC article.
-
Multi-faceted analysis and prediction for the outbreak of pediatric respiratory syncytial virus.J Am Med Inform Assoc. 2023 Dec 22;31(1):198-208. doi: 10.1093/jamia/ocad212. J Am Med Inform Assoc. 2023. PMID: 37934728
-
Respiratory Syncytial Virus Burden and Healthcare Utilization in United States Infants <1 Year of Age: Study of Nationally Representative Databases, 2011-2019.J Infect Dis. 2022 Aug 15;226(Suppl 2):S184-S194. doi: 10.1093/infdis/jiac155. J Infect Dis. 2022. PMID: 35968879 Free PMC article.
-
Respiratory Syncytial Virus Is the Leading Cause of United States Infant Hospitalizations, 2009-2019: A Study of the National (Nationwide) Inpatient Sample.J Infect Dis. 2022 Aug 15;226(Suppl 2):S154-S163. doi: 10.1093/infdis/jiac120. J Infect Dis. 2022. PMID: 35968878 Free PMC article.
References
-
- Driscoll AJ, Arshad SH, Bont L, et al. . Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a World Health Organization-sponsored meeting. Vaccine 2020; 38:2435–48. - PMC - PubMed
-
- Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr 2003; 143:S127–32. - PubMed
-
- Ledbetter J, Brannman L, Wade SW, Gonzales T, Kong AM. Healthcare resource utilization and costs in the 12 months following hospitalization for respiratory syncytial virus or unspecified bronchiolitis among infants. J Med Econ 2020; 23:139–47. - PubMed
-
- Rha B, Curns AT, Lively JY, et al. . Respiratory syncytial virus-associated hospitalizations among young children: 2015-2016. Pediatrics 2020; 146:e20193611. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous